Alivus Life Sciences Ltd.

The revenue for the June 2023 quarter is pegged at Rs. 5784.50 millions, about 18.08% up against Rs. 4898.70 millions recorded during the year-ago period.A slim rise of 24.57% was recorded in the Net profit for the quarter ended June 2023 to Rs. 1354.50  millions  From Rs. 1087.33 millions.Operating profit for the quarter ended June 2023 rose to 1950.12 millions as compared to 1562.61 millions of corresponding quarter ended June 2022.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202306	202206	% Var	202306	202206	% Var	202303	202203	% Var
Sales	5784.50	4898.70	18.08	5784.50	4898.70	18.08	21612.20	21232.14	1.79
Other Income	18.51	94.93	-80.50	18.51	94.93	-80.50	289.57	147.04	96.93
PBIDT	1950.12	1562.61	24.80	1950.12	1562.61	24.80	6712.50	6307.64	6.42
Interest	3.96	1.35	193.33	3.96	1.35	193.33	5.47	279.62	-98.04
PBDT	1946.16	1561.26	24.65	1946.16	1561.26	24.65	6707.03	6028.02	11.26
Depreciation	126.12	98.79	27.66	126.12	98.79	27.66	420.94	378.77	11.13
PBT	1820.04	1462.47	24.45	1820.04	1462.47	24.45	6286.09	5649.25	11.27
TAX	465.54	375.14	24.10	465.54	375.14	24.10	1616.48	1462.01	10.57
Deferred Tax	29.55	12.85	129.96	29.55	12.85	129.96	110.37	85.74	28.73
PAT	1354.50	1087.33	24.57	1354.50	1087.33	24.57	4669.61	4187.24	11.52
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	33.71	31.90	5.69	33.71	31.90	5.69	31.06	29.71	4.55